European Pharmaceutical Review

OCTOBER 20, 2022

In recent years there has been significant development within the cell therapy field, as chimeric antigen receptor (CAR) T-cell therapy demonstrated an ability to transform the treatment of patients with haematological malignancies. Recognising the potential of CAR T cells to act as highly targeted therapeutics, several biotechnology companies – including Sangamo Therapeutics – have established development pipelines of CAR T regulatory cells (Tregs) that aim to tackle immune?

Engineering 125

Engineering Side effects Manufacturing Patients 125

pharmaphorum

OCTOBER 20, 2022

And the LIVE coverage continues as we head into Day Two… This day is set to hold even more points of interest, with the demonstration ‘CX innovation: building experiences that work for customers’ (moderated by Healthware Group’s global head of digital strategy and customer engagement Yannick Valenti), as well as the masterclass ‘How to maximise learning science to affect behaviour change’ with Meducate Global’s president, Lawrence Sherman, and MD of Healthware MedComms & SWM, Francis M

Healthcare 106

Healthcare Healthcare Sales Marketing 106

MedCity News

OCTOBER 20, 2022

Gene therapy can offer hope to patients with previously untreatable diseases, but there’s more work to be done to improve both the safety and efficacy of this therapeutic modality.

Safety 104

Safety Patients Biopharma 104

European Pharmaceutical Review

OCTOBER 20, 2022

Apogenix , a biopharmaceutical company developing next generation immunotherapeutics, announced that asunercept showed statistically significant benefits for hospitalised COVID-19 patients in the ASUNCTIS trial. Apogenix’s lead immunotherapy candidate, asunercept is a fully human fusion protein, consisting of the CD95 receptor and an IgG1 antibody. It is being developed for the treatment of solid tumours, haematological malignancies and viral infections such as COVID-19.

Patients 101

Patients Safety Medicine Leads 101

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

MedCity News

OCTOBER 20, 2022

Texting has the power to help you build relationships, especially since it fits into most peoples’ schedules, and takes almost no effort to read and respond to.

Marketing 109

Marketing Physicians Patients 109

European Pharmaceutical Review

OCTOBER 20, 2022

City of Hope , one of the largest cancer research and treatment organisations in the US, announced that the first patient to receive novel cancer medicine AOH1996, is doing well. The Phase I clinical trial is open at City of Hope Los Angeles. Its objective is to determine the maximum tolerated dose of the investigational pill, AOH1996, and to evaluate the medicine for preliminary efficacy.

Patients 96

Patients Medicine Safety Medical 96

PharmaVoice

OCTOBER 20, 2022

The healthcare giant showed pharmaceutical gains, but that's no thanks to the economic environment of persistent inflation and a strong U.S. dollar.

Pharma 105

Pharma Healthcare Healthcare Pharmaceutical 105

MedCity News

OCTOBER 20, 2022

Thirty five state attorneys general signed an amicus brief claiming that Oklahoma state law should […].

Management 124

Management 124

European Pharmaceutical Review

OCTOBER 20, 2022

An essential part of the manufacturing of drug products is the use of water of different degrees of purity. The US Food and Drug Administration (FDA) defines eight different types of water: non-potable, potable (drinkable), purified, water for injection (WFI), sterile water for injection, sterile water for inhalation, bacteriostatic water for injection and sterile water for irrigation. 1 The last four are produced at separate plants and thus less discussed for pharma since they are unlikely to b

Food and Drug Administration 91

Food and Drug Administration Pharma Manufacturing Food 91

MedCity News

OCTOBER 20, 2022

Traditionally a wellness company focused on meditation and relaxation, Calm is moving into the healthcare space with a new solution called Calm Health. The solution will launch early next year and will cater to payers, providers and self-insured employers.

Insurance 95

Insurance Healthcare Healthcare 95

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Medgadget

OCTOBER 20, 2022

Scientists at Cortical Labs in Melbourne, Australia, along with international collaborators, have developed “DishBrain”, which is essentially a collection of neurons in a dish that have demonstrated learning and, incredibly, can play the classic computer game Pong. The findings could create exciting new opportunities to understand the human brain, model neurological diseases, and test the effects of medications on the brain more easily.

Electronics 91

Electronics Networking Medical 91

MedCity News

OCTOBER 20, 2022

Hospitals and health systems must take a comprehensive and proactive stance to protect themselves from emerging competition in telemedicine and shore up operational practices.

Competition 95

Competition 95

pharmaphorum

OCTOBER 20, 2022

Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceutical companies that spans teams, functions, and geographies. Together, these groups compile vast amounts of data, including rich information on patient populations, target customers, and the competitive landscape. But after months of effort, in most cases, the usefulness of this data begins and ends in a static slide deck or spreadsheet.

Competition 87

Competition Marketing Pharma Biopharma 87

MedCity News

OCTOBER 20, 2022

Price transparency data has revealed there is a high degree of price variance for healthcare procedures depending on patients’ insurance carriers and the location in which services are delivered. Jaewon Ryu, Geisinger’s president and CEO, said that the only way this variability can be addressed is by getting decision makers on the payment side much more aligned with the care delivery side of things.

Insurance 92

Insurance Healthcare Healthcare Patients 92

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

European Pharmaceutical Review

OCTOBER 20, 2022

Gedeon Richter has announced that its combined oral contraceptive Drovelis® is the first tablet containing estetrol (E4) and drospirenone (DRSP) to be made available on the NHS in England. The drug (14.2mg estetrol and 3mg drospirenone) is the first oral combined contraceptive containing a new, synthetic natural oestrogen to be offered to patients in the UK.

Safety 84

Safety Consulting Medicine Healthcare 84

MedCity News

OCTOBER 20, 2022

Prime Medicine has yet to test prime editing in humans, but the biotech company garnered enough investor interest to boost the size of its IPO, raising $175 million. Prime claims its technology has key advantages over other gene-editing technologies and the IPO cash will support a pipeline that currently spans 18 programs.

Medicine 92

Medicine Biopharma Pharma 92

PharmaVoice

OCTOBER 20, 2022

Colossal Biosciences announced the creation of Form Bio — and its “operating system for science” — in September.

98

98

MedCity News

OCTOBER 20, 2022

Emblem Health’ s chief financial officer knows that prior authorization — where patients have to […].

Patients 107

Patients Electronics Physicians 107

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

Pharma Pathway

OCTOBER 20, 2022

Job Description. Alembic Pharmaceuticals Ltd. is one of the leading API & Formulations manufacturing and marketing pharmaceutical Company. We continue to enjoy leadership positions in antibiotics, anti -infective, anti -cough and also have significant worldwide presence in specialty therapeutic area such as cardiology, neurology, diabetology, etc.

Pharmaceutical 81

Pharmaceutical Distribution Prescription Doctors 81

MedCity News

OCTOBER 20, 2022

The Covid-19 pandemic challenged the U.S. healthcare system like never before—particularly the segment of the […].

Healthcare 103

Healthcare Healthcare 103

Impetus Digital

OCTOBER 20, 2022

1. Advisor preference! Let’s jump right in, shall we? After more than two years of pandemic restrictions, many Pharma leaders are itching to meet with their key opinion leaders (KOLs) face-to-face again, believing that’s what most KOLs want. It may come as a surprise that this is not always the case. Based on over a decade of feedback from thousands of healthcare provider (HCP) advisors, across all therapeutic areas, we are consistently hearing that asynchronous virtual touchpoints (AVTs)

Healthcare Provider 81

Healthcare Provider Transportation Pharma Healthcare 81

MedCity News

OCTOBER 20, 2022

As hospitals face consolidation and CIOs are asked to increase staff productivity, tech companies that can support automation with solutions that are easy to onboard are getting heightened interest.

Patients 81

Patients 81

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management

Pharma Pathway

OCTOBER 20, 2022

Aurigene -Hiring Team Leader- DMPK / Medicinal Chemistry/ Microbiology/ Invitro Bio- Apply Now. Job Description. We are hiring Team Leaders in our growing scientific. Candidates with PhD in respective subjects and 5 years of experience can share your profile on krishnafulsure@aurigeneservices.com , nareshd@aurigeneservices.com. Hiring Team Leader- DMPK / Medicinal Chemistry/ Microbiology/ Invitro Bio.

Medicine 80

Medicine 80

MedCity News

OCTOBER 20, 2022

Solv has added direct real-time booking to Solv Connect, its marketplace for same-day and next-day healthcare appointments. This announcement decouples Solv Connect from the company’s other software offering, Solv Experience, which is its practice management platform. The first customer the company is announcing for its new-and-improved Solv Connect offering is Carbon Health, a network of primary care and urgent care clinics.

Networking 80

Networking Healthcare Healthcare Management 80

pharmaphorum

OCTOBER 20, 2022

In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLennan travelled to Nice for the Reuters Pharma event. This special episode includes a conversation recorded on-site with Nicole, Eloise, Virtual Science AI CEO Thomas Hughes, and VSAI VP of global patient affairs Geraldine Reilly. They discuss key takeaways from the event, major trends in the space, and the guests’ work at Virtual Science AI, using technology to help life sciences companies create virtual patient adviso

Pharma 77

Pharma Specialization Consulting Patients 77

MedCity News

OCTOBER 20, 2022

President of Humana’s primary care, Reneé Buckingham, addresses the needs of many seniors facing multiple diagnoses and barriers to high-quality care.

79

79

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

PharmaTimes

OCTOBER 20, 2022

Statistics show an average of 789 new malignant cancers diagnosed per day in 2020

95

95

Quantified

OCTOBER 20, 2022

The way we sell is changing. Sales organizations operate in a progressively changing environment. From the sudden shift to remote and virtual selling during COVID to the economic downturn, sales leaders continue to evolve what they have to do to perform. And with so many negative factors outside the company’s control, the attention naturally shifts to improving internal processes to gain a competitive advantage and achieve sales excellence on multiple levels.

Sales 52

Sales Sales Management Sales technology Management 52

Legacy MEDSearch

OCTOBER 20, 2022

Eyenuk, Inc., a global artificial intelligence (AI) digital health company and the leader in real-world applications for AI Eye Screening and AI Predictive Biomarkers , announced it has secured $26 million in a Series A financing round, bringing the Company’s total funding to over $43 million. The capital raise was led by AXA IM Alts and was joined by new and existing investors including T&W Medical A/S, A&C Foelsgaard Alternativer ApS, Kendall Capital Partners, and KOFA Healthcare

Healthcare 52

Healthcare Healthcare Recruitment Medical 52

CLD, Inc.

OCTOBER 20, 2022

Heist Escape Room, Selling Zone, & Game Zone workshop for 300+ biotech sales representatives. The meeting brought everyone at this top 10 biotech company together after two plus years of remote and virtual meetings.

Sales 52

Sales 52

Advertisement

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

Patients